澳洋健康迎国资入主复牌涨停 实控人等套现5.93亿元

Group 1 - Aoyang Health (002172.SZ) experienced a trading halt and subsequently resumed trading on September 16, 2025, with a price of 4.73 yuan, reflecting a 10.00% increase [1] - The company announced a significant change in control, with its controlling shareholder Aoyang Group planning to transfer 20% of its shares, totaling 153,146,472 shares, to Yuesheng Technology at a price of 3.87 yuan per share, amounting to approximately 592.68 million yuan [1][2] - Following the share transfer, the controlling shareholder will shift from Aoyang Group to Yuesheng Technology, and the actual controller will change from Shen Xue Ru to the Management Committee of Zhangjiagang Economic and Technological Development Zone [2] Group 2 - Aoyang Health reported a 12.49% year-on-year decline in revenue for the first half of 2025, totaling 903 million yuan, compared to 1.03 billion yuan in the same period last year [3][4] - The net profit attributable to shareholders decreased by 15.46% to approximately 31.56 million yuan, down from 37.33 million yuan year-on-year [3][4] - The net cash flow from operating activities was negative at approximately -55.13 million yuan, showing a significant improvement of 78.25% compared to the previous year's -253.41 million yuan [3][4]